A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Heerspink Hiddo J. L. and Cherney David and Kollaborációs szerevezet: DAPA-CKD Trial Committees and Investigators and Wittmann I. and Vörös P. and Dudás M. and Tabak G. A. and Kirschner R. and Letoha Annamária and Balku I. and Hermanyi Z. and Zakar G. and Mezei I. and Nagy G. G. and Lippai J. and Németh A.: A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
KIDNEY INTERNATIONAL, 101 (1). pp. 174-184. ISSN 0085-2538 (2021)

[thumbnail of HeerspinkKidneyInt2021.pdf]
Preview
Text
HeerspinkKidneyInt2021.pdf - Accepted Version

Download (729kB) | Preview
Creators:
Heerspink Hiddo J. L.
Cherney David
Kollaborációs szerevezet: DAPA-CKD Trial Committees and Investigators
Wittmann I. (kollab)
Vörös P. (kollab)
Dudás M. (kollab)
Tabak G. A. (kollab)
Kirschner R. (kollab)
Letoha Annamária (kollab) MTMT
Balku I. (kollab)
Hermanyi Z. (kollab)
Zakar G. (kollab)
Mezei I. (kollab)
Nagy G. G. (kollab)
Lippai J. (kollab)
Németh A. (kollab)
Item Type: Journal Article
Szerzők száma: 430
Journal or Publication Title: KIDNEY INTERNATIONAL
Date: 2021
Volume: 101
Number: 1
Page Range: pp. 174-184
ISSN: 0085-2538
Faculty/Unit: Albert Szent-Györgyi Medical School
Institution: University of Szeged (2000-)
Language: English
MTMT rekordazonosító: 32539647
DOI azonosító: https://doi.org/10.1016/j.kint.2021.09.005
Date Deposited: 2021. Dec. 16. 08:47
Last Modified: 2022. Mar. 07. 12:37
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/23067
Web of Science® Times Cited: 60 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year